SILLY, ANALOS rebounded to $0.145, $0.00035
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Immunology and inflammation biotech company Bambusa (BBTX.US) prices IPO at $15-17 per share, aims to raise $150 million.
Bambusa Therapeutics plans to raise 150 millions USD by issuing 9.4 million shares at a price range of 15 to 17 USD per share.
The Bank of Japan’s price trend indicator rises above 3%, providing grounds for further rate hikes
The Bank of Japan's indicator for measuring underlying inflation has risen to its highest level in three years, far surpassing the bank's 2% target, providing grounds for authorities to continue raising interest rates.
$95 billion bet on AI! Meta (META.US) launches rare equity financing, while Goldman Sachs still maintains "Buy" rating
Meta announced a $95 billion equity financing, with NVIDIA, AMD, and Broadcom planning to subscribe $5 billion. Goldman Sachs reiterated its "buy" rating with a target price of $885.
Heimstaden Q3 Rental Income Rises to SEK 4.04 Billion
Crypto prices
More
